$307.65
-1.07-0.35%
At close: -
$302.50
-5.15-1.67%
After Hours: 4:34 PM EDT
Comments
Loading...
United Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:UTHR | Benzinga
United Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 30
EPS
$6.630
Quarterly Revenue
$794.40M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.99B
Analyze the earnings history of United Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UTHR | United Therapeutics | $5.85 | — | — | — | $714.90M | — | — | — | 07/30/2025 | Get Alert |
| UTHR | United Therapeutics | $6.17 | $6.53 | $6.63 | 1.53% | $677.70M | $729.82M | $794.40M | 8.85% | 04/30/2025 | Get Alert |
| UTHR | United Therapeutics | $4.36 | $6.31 | $6.19 | -1.90% | $614.70M | $734.74M | $735.90M | 0.16% | 02/26/2025 | Get Alert |
| UTHR | United Therapeutics | $5.38 | $6.42 | $6.39 | -0.47% | $609.40M | $722.58M | $748.90M | 3.64% | 10/30/2024 | Get Alert |
| UTHR | United Therapeutics | $5.24 | $6.40 | $5.85 | -8.59% | $596.50M | $691.87M | $714.90M | 3.33% | 07/31/2024 | Get Alert |
| UTHR | United Therapeutics | $4.86 | $5.65 | $6.17 | 9.20% | $506.90M | $623.97M | $677.70M | 8.61% | 05/01/2024 | Get Alert |
| UTHR | United Therapeutics | $2.67 | $4.19 | $4.36 | 4.06% | $491.50M | $575.87M | $614.70M | 6.74% | 02/21/2024 | Get Alert |
| UTHR | United Therapeutics | $4.91 | $5.08 | $5.38 | 5.91% | $516.00M | $587.90M | $609.40M | 3.66% | 11/01/2023 | Get Alert |
| UTHR | United Therapeutics | $2.41 | $4.41 | $5.24 | 18.82% | $466.90M | $532.33M | $596.50M | 12.05% | 08/02/2023 | Get Alert |
| UTHR | United Therapeutics | $5.03 | $4.52 | $4.86 | 7.52% | $461.90M | $514.37M | $506.90M | -1.45% | 05/03/2023 | Get Alert |
| UTHR | United Therapeutics | $3.51 | $4.51 | $2.67 | -40.80% | $415.20M | $519.21M | $491.50M | -5.34% | 02/22/2023 | Get Alert |
| UTHR | United Therapeutics | $3.42 | $3.89 | $4.91 | 26.22% | $444.70M | $493.20M | $516.00M | 4.62% | 11/02/2022 | Get Alert |
| UTHR | United Therapeutics | $3.65 | $4.12 | $2.41 | -41.50% | $446.50M | $461.06M | $466.90M | 1.27% | 08/03/2022 | Get Alert |
| UTHR | United Therapeutics | $3.49 | $3.34 | $5.03 | 50.60% | $379.10M | $420.02M | $461.90M | 9.97% | 05/04/2022 | Get Alert |
| UTHR | United Therapeutics | $3.31 | $3.72 | $3.51 | -5.65% | $384.90M | $427.62M | $415.20M | -2.90% | 02/24/2022 | Get Alert |
| UTHR | United Therapeutics | $3.88 | $3.59 | $4.16 | 15.88% | $380.10M | $421.45M | $444.70M | 5.52% | 11/03/2021 | Get Alert |
| UTHR | United Therapeutics | $3.68 | $3.02 | $4.09 | 35.43% | $362.00M | $378.75M | $446.50M | 17.89% | 08/04/2021 | Get Alert |
| UTHR | United Therapeutics | $3.61 | $2.94 | $3.49 | 18.71% | $356.30M | $368.95M | $379.10M | 2.75% | 05/05/2021 | Get Alert |
| UTHR | United Therapeutics | $1.96 | $3.14 | $3.31 | 5.41% | $311.10M | $361.07M | $384.90M | 6.60% | 02/24/2021 | Get Alert |
| UTHR | United Therapeutics | $3.83 | $2.78 | $3.88 | 39.57% | $401.50M | $356.95M | $380.10M | 6.49% | 10/28/2020 | Get Alert |
| UTHR | United Therapeutics | $3.63 | $2.80 | $3.68 | 31.43% | $373.60M | $338.47M | $362.00M | 6.95% | 07/29/2020 | Get Alert |
United Therapeutics (UTHR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-04-30 | $6.63 | $6.53 | 1.53 % |
| Q4 | 2025-02-26 | $6.19 | $6.31 | -1.90 % |
| Q3 | 2024-10-30 | $6.39 | $6.42 | -0.47 % |
| Q2 | 2024-07-31 | $5.85 | $6.40 | -8.59 % |
United Therapeutics (UTHR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-04-30 | $794.40M | $729.82M | 8.85 % |
| Q4 | 2025-02-26 | $735.90M | $734.74M | 0.16 % |
| Q3 | 2024-10-30 | $748.90M | $722.58M | 3.64 % |
| Q2 | 2024-07-31 | $714.90M | $691.87M | 3.33 % |
FAQ
When is United Therapeutics (NASDAQ:UTHR) reporting earnings?
United Therapeutics (UTHR) is scheduled to report earnings on July 30, 2025. The last reported earnings were for reported on April 30, 2025 for Q1.
What were the latest earnings per share (EPS) for United Therapeutics (NASDAQ:UTHR)?
The Actual EPS was $6.63, which beat the estimate of $6.53.
What were United Therapeutics’s (NASDAQ:UTHR) revenues?
The Actual Revenue was $794.4M, which beat the estimate of $729.8M.
Browse earnings estimates, EPS, and revenue on all stocks.
